Amy E. Baxter,Hua Huang,Josephine R. Giles,Zeyu Chen,Jennifer E. Wu,Sydney Drury,Katherine Dalton,Simone L. Park,Leonel Torres,Brandon W. Simone,Max Klapholz,Shin Foong Ngiow,Elizabeth Freilich,Sasikanth Manne,Víctor Alcalde,Viktoriya Ekshyyan,Shelley L. Berger,Junwei Shi,Martha S. Jordan,E. John Wherry
CD8+ T cell exhaustion (Tex) limits disease control during chronic viral infections and cancer. Here, we investigated the epigenetic factors mediating major chromatin-remodeling events in Tex-cell development. A protein-domain-focused in vivo CRISPR screen identified distinct functions for two versions of the SWI/SNF chromatin-remodeling complex in Tex-cell differentiation. Depletion of the canonical SWI/SNF form, BAF, impaired initial CD8+ T cell responses in acute and chronic infection. In contrast, disruption of PBAF enhanced Tex-cell proliferation and survival. Mechanistically, PBAF regulated the epigenetic and transcriptional transition from TCF-1+ progenitor Tex cells to more differentiated TCF-1- Tex subsets. Whereas PBAF acted to preserve Tex progenitor biology, BAF was required to generate effector-like Tex cells, suggesting that the balance of these factors coordinates Tex-cell subset differentiation. Targeting PBAF improved tumor control both alone and in combination with anti-PD-L1 immunotherapy. Thus, PBAF may present a therapeutic target in cancer immunotherapy.